Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: PMA announcement procedures

This article was originally published in The Gray Sheet

Executive Summary

PMA announcement procedures: Notices of approvals and denials of premarket approval applications will appear on the Center for Devices and Radiological Health home page beginning March 2, according to a Jan. 30 final rule published by FDA in the Federal Register. A quarterly list of reviewed devices and their status will be posted on the Internet, replacing the practice of publishing individual notices in the Register. FDA opted for the new format because "announcements can be placed on the Internet more quickly than they can be published in the Federal Register" and "the Internet is accessible to more people." Firms will continue to be allotted 30 days following the release of the list to petition the agency's decision on the PMA...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009552

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel